GBS Venture Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
69
- Portfolio
-
2
- Exits
-
41

GBS Venture Partners General Information
Description
Founded in 1996, GBS Venture Partners Limited is a venture capital firm based in Melbourne, Australia. The firm specializes in investment in companies involved in technologies in human healthcare and biotechnology product development with a focus on human therapeutics and diagnostics, animal therapeutics and diagnostics, medical devices, health information technology, agribusiness, food, and environmental technology sectors.
Contact Information
Website
www.gbsventures.com.au
Year Founded
1996
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- Harley House, Level 5
- 71 Collins Street
- Melbourne, Victoria 3000
- Australia
+61 (03) 0000 0000
GBS Venture Partners Investments & Acquisitions (69)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Moximed | 16-Aug-2022 | Later Stage VC | 0000 | Therapeutic Devices | Generating Revenue | 00000000 00000 |
0000000 | 16-Mar-2017 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 00000000 00000 |
0000000 | 09-Jan-2017 | 00000 00000 | 0000 | Surgical Devices | Generating Revenue | 000 0000 |
000000000 | 01-Jun-2016 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 000000 000000 00.0 |
0000000000 | 29-Jun-2015 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 | 000000 000000 00.0 |
0000000 | 07-May-2015 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 00000000 00000 |
0000000 | 22-Sep-2014 | 00000 00000 | 000.00 | Surgical Devices | Generating Revenue | 000 0000 |
00000000 000000000 | 11-Apr-2014 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000000 000000 00.0 |
Mimetica | 07-Mar-2014 | Later Stage VC | 000 | Drug Discovery | Out of Business | 000 0000 |
Hydrexia | 08-May-2013 | Later Stage VC | 00.00 | Energy Storage | Out of Business |
GBS Venture Partners Exits (41)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Ivantis | 07-Jan-2022 | Merger/Acquisition | 00000 |
00000000 | 19-Apr-2021 | 000 00 00000000 | |
00000000 | 01-Mar-2021 | 000 00 00000000 | |
00000000000 | 01-Mar-2021 | 000000000 00000000 | |
00000000 | 01-Jan-2019 | 000000000 00000000 | |
000000000 | 06-Apr-2018 | 000000000000000000 | 00000 |
000000000 00000000 | 01-Nov-2017 | 000000000000000000 | |
00000000 | 05-May-2017 | 000000000000000000 | 000 |
Viveve | 17-Mar-2017 | Public Investment 2nd Offering | 0000 |
Neurovance | 01-Mar-2017 | Merger/Acquisition | 00000 |
GBS Venture Partners Investments by Industry, Year, and Region
GBS Venture Partners Team (9)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Geoffrey Brooke MD | Co-Founder | 0 | 0 | Melbourne, Australia | |
Brigitte Smith | Co-Founder & Managing Partner | 00 | 0 | 0 | Melbourne, Australia |
Ben Gust | Partner | 00 | 0 | 0 | Melbourne, Australia |
GBS Venture Partners Co-Investors (7)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Advent Life Sciences | 1 | 0 |
![]() |
![]() |
|
Australia Future Fund | 0 | 0 |
![]() |
![]() |
|
Gilde Healthcare | 0 | 0 |
![]() |
![]() |
|
Morgenthaler Ventures | 0 | 0 |
![]() |
![]() |
|
New Enterprise Associates | 0 | 0 |
![]() |
![]() |